The go-or-grow hypothesis states that adherent cells undergo reversible phenotype switching between migratory and proliferative states, with cells in the migratory state being more motile than cells in the proliferative state. Here we examine go-or-grow in 2-D in vitro assays using melanoma cells with fluorescent cell-cycle indicators and cell cycle-inhibiting drugs. We analyse the experimental data using single-cell tracking to calculate mean diffusivities, and compare motility between cells in different cell-cycle phases and in cell-cycle arrest. Unequivocally, our analysis does not support the goor-grow hypothesis. We present clear evidence that cell motility is independent of the cell-cycle phase, and non-proliferative arrested cells have the same motility as cycling cells.
cell cycle-inhibiting drugs [8, 14, 15 ]. An arrested cell is not proliferative, so the cell's free energy could be utilised for migration, potentially leading to an exacerbation of metastasis [3] .
The go-or-grow hypothesis also has important implications for mathematical models of collective cell invasion in a population of migratory and proliferative cells. Such models of cell invasion are often based on the Fisher-Kolmogorov-Petrovskii-Piskunov (FKPP) equation [16] [17] [18] [19] ,
where x is position, t is time, u(x, t) > 0 is cell density, D > 0 is the diffusivity, λ > 0 is the proliferation rate, and K > 0 is the carrying-capacity density. Eq. (1) and related adaptations, including stochastic analogues [20, 21] , have been successfully used to model cell migration in vitro and in vivo [22] [23] [24] [25] [26] . A key assumption underlying these models is that D is independent of the cell-cycle phase, which may not hold if cells are subject to go-or-grow as then a cycling, therefore non-arrested, cell may become less motile as it progresses through the cell cycle and nears cell division [8] .
In this work we rigorously examine the go-or-grow hypothesis for adherent melanoma cells, for which phenotype switching between migratory and proliferative states is proposed to occur [1] . We use melanoma cell lines in this study as melanoma is the prototype for the phenotype switching model and is highly responsive to G1 arrest-inducing MEK inhibitors, such as trametinib.
Melanoma cells are therefore an ideal candidate for studying go-or-grow [1, 3, 27] . Our experimental data are obtained from single-cell tracking in 2-D in vitro assays. We conduct our experiments in 2-D as it is the natural situation in which to commence a new experimental study, before utilising the knowledge gained in more complicated 3-D or in vivo experiments. Indeed, experimental studies of cell migration are often conducted in 2-D in vitro assays for several reasons: the observed cell migration is partly representative of cell migration in vivo; the assays are amenable to standard laboratory techniques, such as live-cell microscopy; and the relative ease of image analysis, such as cell counting and single-cell tracking [28] [29] [30] . Further, cell migration in 3-D may be affected by the properties of a 3-D matrix, which is not present in 2-D assays. For example, cell migration in 3-D through constricting pores can damage the nucleus and thereby cause a delay in cell division as the nucleus undergoes repair, which could be interpreted incorrectly as evidence for go-or-grow [31] .
We employ fluorescent ubiquitination-based cell cycle indicator (FUCCI) [32] , which consists of two reporters enabling visualisation of the cell cycle of individual live cells: when the cell is in G1 the nucleus fluoresces red, and when the cell is in S/G2/M the nucleus fluoresces green ( Fig. 1(a) ).
During early S, called eS, both of the red and green reporters are active producing yellow. FUCCI allows us to study cell motility in G1 separately from cell motility in S/G2/M [8, 22, 33, 34] .
Specifically, we investigate cycling cells for differences in motility when the cells are in G1 compared with S/G2/M. Further, given the potential for an arrested cell to become more motile, we use a cell cycle-inhibiting drug to effect G1 arrest, and compare the motility of the arrested cells with cycling cells. Note that FUCCI does not provide delineation of S, G2 and M, so our motility measurements for these phases are combined into S/G2/M.
Our methodology for examining go-or-grow is novel in a number of ways. We induce G1 arrest in cells to determine whether non-proliferative cells have higher motility than cycling cells. We use experimental data to show that our three cell lines have distinctly different cell-cycle durations, ratios of duration in G1 to S/G2/M, and migration characteristics, all of which may affect motility under the go-or-grow hypothesis. Importantly, the data set we generate and analyse is large:
for each cell line and experimental condition we randomly sample 50 single-cell trajectories for analysis out of more than 10 3 trajectories. In total, we analyse 450 carefully-collected trajectories for evidence of go-or-grow. Using these trajectories we carefully estimate diffusivities by first accounting for anisotropy in the cell migration, so that our estimates are based on time frames for which the cells are undergoing free diffusion.
Our data consist of time-series images, acquired every 15 min for 48 h, from 2-D proliferation assays using the melanoma cell lines C8161, WM983C and 1205Lu [8, 22, 35, 36] , which have respective mean cell-cycle durations of approximately 21, 23 and 37 h [8] . The cell lines have very different ratios of durations in G1 to S/G2/M (Supplementary Material). Fig. 1(b )-(c) shows images of an assay with cycling C8161 cells at 0 and 48 h, illustrating the red, yellow and green nuclei corresponding to cells in G1, eS and S/G2/M, respectively. For comparison, Fig. 1(e )-(f)
shows images of an assay with G1-arrested C8161 cells treated with the cell cycle-inhibiting drug trametinib (30 nM), illustrating that most cells are arrested in G1, appearing red. We use the lowest possible concentration of trametinib to induce G1 arrest for the experiment duration to minimise other effects. Consequently, each cell eventually returns to cycling, illustrated by the small proportion of green cells ( Fig. 1(e)-(f) ). These few green cells will eventually divide with both daughter cells arresting in G1. We quantitatively confirm the G1 arrest by comparing the cell counts between the experiments with cycling cells and arrested cells. For the cycling cells there is a 5.7-fold increase in the number of cells over 48 h ( Fig. 1(b)-(c) ), whereas there is only a 1.8-fold increase in the number of arrested cells over 48 h (Fig. 1(e)-(f) ). The 1.8-fold increase in the population of G1-arrested cells is expected as we use the lowest possible concentration of trametinib. Consequently, a small subpopulation of cells may not be arrested at the start of the experiment, and cells may recommence cycling during the experiment, producing a small increase in the population. In Fig. 1(g) -(i) we visualise the trajectories for cycling C8161 in G1 and S/G2/M, and C8161
in G1-arrest. The trajectories are translated so that their initial positions are at the origin. The trajectories of the G1-arrested cells are generally much longer than those for the cycling cells, as the arrested cells reside in G1 for a much longer duration than cycling cells reside in G1 or S/G2/M. Specifically, the approximate mean duration of cycling C8161 cells in G1 is 5 h, in S/G2/M is 6 h [8] , and for cells in G1 arrest during the 48 h of the experiment is 34 h ( Supplementary Material) .
Therefore, to easily compare the trajectories of G1-arrested cells with cycling cells in G1, we show within the inset the truncated trajectories of the G1 arrested cells. The trajectories are truncated to a duration equal to the mean duration of the corresponding trajectories for cycling cells in G1.
Based on these data, the migration is isotropic, without any drift, and independent of the cell cycle phase. We now quantify these observations.
For each cell line and experimental condition, we find that the cell migration is isotropic and directional persistence dissipates within a relatively short lag time of 1 h (Supplementary Material).
From each individual cell trajectory we estimate D, using the mean square displacement as a function of lag time, within 2-h time intervals. The intervals begin at the initial point of the trajectory, t = 0 h, with successive intervals offset by 1 h. We always use lag times from 1-2 h to guarantee the absence of persistence (Supplementary Material). We then calculate the mean diffusivity D for each time interval by averaging our estimates of D for those trajectories that extend to the end of that interval. • For each cell line, there is little variation in D between cycling cells in G1, cycling cells in S/G2/M, and G1-arrested cells. The lack of variability in D is remarkable, and clearly demonstrates that cells in G1 are not more motile than cells in S/G2/M, and that G1-arrested cells at no time become more migratory than the cycling cells.
• Even though our three cell lines have very different proliferation and migration characteristics (Supplementary Material), our estimate of D is remarkably consistent across the three very different cell lines.
In summary, our analysis of cell migration in 2-D assays using three melanoma cell lines does not support the go-or-grow hypothesis. We find that cell motility is independent of the cell-cycle phase, so that the implication from go-or-grow that cells are more motile in G1 than in S/G2/M when they are nearing cell division is not supported by our data. Notably, there is no change in cell motility when we effect drug-induced G1 arrest in the cells, again displaying a lack of support for the go-or-grow hypothesis.
